These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25547608)

  • 41. [Allogeneic hematopoietic stem cell transplantation of myelodysplastic syndrome with pulmonary tuberculosis].
    Yamashita K; Nomiyama J; Takahashi T; Ando T; Tsuru M; Matsubara A; Sato Y; Hatao K; Murakami K; Tanizawa Y
    Nihon Naika Gakkai Zasshi; 2004 Oct; 93(10):2207-9. PubMed ID: 15552923
    [No Abstract]   [Full Text] [Related]  

  • 42. [Allogeneic hematopoietic stem cell transplantation for MDS secondary to Shwachman-Diamond syndrome: a case report].
    Zhou M; Jiang YW; Chen JJ; Wu C; Zou BB; Chen Z; Li L; Lei P; Liu GH; Tian YY; Zhu ML; Liu C
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):80. PubMed ID: 36987731
    [No Abstract]   [Full Text] [Related]  

  • 43. Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.
    Saure C; Schroeder T; Zohren F; Groten A; Bruns I; Czibere A; Galonska L; Kondakci M; Weigelt C; Fenk R; Germing U; Haas R; Kobbe G
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):466-72. PubMed ID: 21963618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older.
    Mukherjee S
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):1-2. PubMed ID: 27865911
    [No Abstract]   [Full Text] [Related]  

  • 45. Autologous stem cell transplantation in myelodysplastic syndromes.
    de Witte T; Suciu S; Brand R; Muus P; Kröger N
    Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.
    Cremers EM; van Biezen A; de Wreede LC; Scholten M; Vitek A; Finke J; Platzbecker U; Beelen D; Schwerdtfeger R; Volin L; Harhalakis N; Blijlevens N; Nagler A; Kröger N; de Witte T
    Ann Hematol; 2016 Dec; 95(12):1971-1978. PubMed ID: 27650829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation.
    Kook MH; Yhim HY; Lee NR; Song EK; Kim HS; Yim CY; Kwak JY
    Korean J Intern Med; 2014 Jan; 29(1):123-5. PubMed ID: 24574844
    [No Abstract]   [Full Text] [Related]  

  • 48. The Art of Transplantation: Conditioning Intensity for Allogeneic Hematopoietic Stem Cell Transplantation.
    Ragon BK
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):e71-e72. PubMed ID: 30562588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress in intensive chemotherapy for high-risk myelodysplastic syndromes.
    Sanz GF; Sanz MA
    Forum (Genova); 1999; 9(1):63-71. PubMed ID: 10101211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
    de Lima M; Champlin RE; Thall PF; Wang X; Martin TG; Cook JD; McCormick G; Qazilbash M; Kebriaei P; Couriel D; Shpall EJ; Khouri I; Anderlini P; Hosing C; Chan KW; Andersson BS; Patah PA; Caldera Z; Jabbour E; Giralt S
    Leukemia; 2008 Feb; 22(2):258-64. PubMed ID: 17989720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
    Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
    de Lima M; Giralt S
    Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient.
    Fujiwara Y; Matsuoka KI; Iwamoto M; Sumii Y; Abe M; Mizuhara K; Urata T; Saeki K; Meguri Y; Asada N; Ennishi D; Nishimori H; Fujii K; Fujii N; Sugita J; Kobayashi H; Oto T; Maeda Y
    Int J Hematol; 2020 Dec; 112(6):871-877. PubMed ID: 32803699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.
    Yoon JH; Jeon YW; Yahng SA; Shin SH; Lee SE; Cho BS; Lee DG; Eom KS; Kim HJ; Lee S; Min CK; Cho SG; Kim Y; Kim DW; Lee JW; Han K; Min WS; Park CW; Kim M; Kim YJ
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):460-7. PubMed ID: 25460359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts.
    Yahng SA; Kim M; Kim TM; Jeon YW; Yoon JH; Shin SH; Lee SE; Eom KS; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Kim YJ
    Oncotarget; 2017 Feb; 8(7):12342-12354. PubMed ID: 27729615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enlarged spleen is associated with low neutrophil and platelet engraftment rates and poor survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Shimomura Y; Hara M; Katoh D; Hashimoto H; Ishikawa T
    Ann Hematol; 2018 Jun; 97(6):1049-1056. PubMed ID: 29455235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis.
    Zhang ZH; Lian XY; Yao DM; He PF; Ma JC; Xu ZJ; Guo H; Zhang W; Lin J; Qian J
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1853-1864. PubMed ID: 28470473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease.
    Chan GW; Foss FM; Klein AK; Sprague K; Miller KB
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):753-9. PubMed ID: 14677114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic transplantation for myelodysplastic syndrome (MDS).
    Ingram W; Lim ZY; Mufti GJ
    Blood Rev; 2007 Mar; 21(2):61-71. PubMed ID: 16759774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.